[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,871,021
  • Shares Outstanding, K 13,274
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 265,240 K
  • EBIT $ 394 M
  • EBITDA $ 459 M
  • 60-Month Beta 0.52
  • Price/Sales 2.67
  • Price/Cash Flow 20.65
  • Price/Book 7.97

Options Overview Details

View History
  • Implied Volatility 25.24% (-14.56%)
  • Historical Volatility 21.52%
  • IV Percentile 24%
  • IV Rank 19.56%
  • IV High 43.94% on 10/28/25
  • IV Low 20.69% on 01/16/26
  • Expected Move (DTE 22) 10.37 (1.92%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 91
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 3,002
  • Open Int (30-Day) 2,696
  • Expected Range 528.99 to 549.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $5.58
  • Number of Estimates 1
  • High Estimate $5.58
  • Low Estimate $5.58
  • Prior Year $4.94
  • Growth Rate Est. (year over year) +12.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
457.35 +17.93%
on 06/30/26
551.68 -2.23%
on 07/29/26
+79.46 (+17.28%)
since 06/29/26
3-Month
404.26 +33.42%
on 05/13/26
551.68 -2.23%
on 07/29/26
+115.42 (+27.23%)
since 04/29/26
52-Week
365.20 +47.69%
on 03/27/26
551.68 -2.23%
on 07/29/26
+74.67 (+16.07%)
since 07/29/25

Most Recent Stories

More News
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook

CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook

CHE : 539.36 (+4.20%)
Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations

Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations

CHE : 539.36 (+4.20%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 539.36 (+4.20%)
Chemed Reports Second-Quarter 2026 Results

CINCINNATI, July 28, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and...

CHE : 539.36 (+4.20%)
Chemed (CHE) Q2 Earnings: What To Expect

Chemed (CHE) Q2 Earnings: What To Expect

CHE : 539.36 (+4.20%)
3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar

CHE : 539.36 (+4.20%)
VTRS : 17.82 (-0.22%)
BMY : 63.10 (-0.79%)
3 Unpopular Stocks We’re Skeptical Of

3 Unpopular Stocks We’re Skeptical Of

CHE : 539.36 (+4.20%)
UPS : 104.56 (-0.92%)
OKTA : 136.91 (+0.51%)
3 Reasons to Sell CHE and 1 Stock to Buy Instead

3 Reasons to Sell CHE and 1 Stock to Buy Instead

CHE : 539.36 (+4.20%)
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29

CINCINNATI, July 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2026, on Tuesday, July 28,...

CHE : 539.36 (+4.20%)
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q1 Earnings: Chemed (NYSE:CHE) Vs The Rest Of The Pack

A Look Back at Senior Health, Home Health & Hospice Stocks’ Q1 Earnings: Chemed (NYSE:CHE) Vs The Rest Of The Pack

CHE : 539.36 (+4.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 581.79
2nd Resistance Point 566.73
1st Resistance Point 553.05
Last Price 539.36
1st Support Level 524.31
2nd Support Level 509.25
3rd Support Level 495.57

See More

52-Week High 551.68
Last Price 539.36
Fibonacci 61.8% 480.45
Fibonacci 50% 458.44
Fibonacci 38.2% 436.44
52-Week Low 365.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.